The Covid-19 pandemic has infected millions of people across the world and caused several thousands of deaths. Given advances in extracorporeal life suppirt technology, ECMO for Covid-19 ARDS has proven to be successful in sustaining life, however has left a significant number of patients fully dependen on devices and incapable of beaing weaned. Lung transplantation, as a well-established therapy for end-stage lung disease, has been considered for some patients with Covid-19 ARD in the absence of lung recovery and the presence of findings suggestive of end-stage lung disease
International Experience with Lung Transplantation for COVID-19 Associated Acute Respiratory Distress Syndrome / T.N. Machuca, A. Bharat, C. Kurihara, R.G. Jr, S. Kim, A. Manerikar, A. Pelaez, M. Pipkin, A. Shahmohammadi, M. Rackauskas, S. Kg, K. Balakrishnan, A. Jindal, L. Schaheen, S. Hashimi, B. Bhuddhdev, A. Arjuna, L. Rosso, A. Palleschi, C. Lang, P. Jaksch, M. Nosotti, K. Hoetzenecker. - In: THE JOURNAL OF HEART AND LUNG TRANSPLANTATION. - ISSN 1053-2498. - 40:4(2021 Apr), pp. S12-S12. ((Intervento presentato al convegno The ISHLT2021 Annual Meeting & Scientific Sessions nel 2021.
International Experience with Lung Transplantation for COVID-19 Associated Acute Respiratory Distress Syndrome
L. Rosso;A. Palleschi;M. NosottiPenultimo
;
2021
Abstract
The Covid-19 pandemic has infected millions of people across the world and caused several thousands of deaths. Given advances in extracorporeal life suppirt technology, ECMO for Covid-19 ARDS has proven to be successful in sustaining life, however has left a significant number of patients fully dependen on devices and incapable of beaing weaned. Lung transplantation, as a well-established therapy for end-stage lung disease, has been considered for some patients with Covid-19 ARD in the absence of lung recovery and the presence of findings suggestive of end-stage lung diseaseFile | Dimensione | Formato | |
---|---|---|---|
ISHLT 2021 International Experience with Lung Tx for COVID-19... PUBBLICATO.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
2.72 MB
Formato
Adobe PDF
|
2.72 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.